GSTM1 and anemia: This cross-sectional study, conducted at a tertiary care hospital from April 2024 to November 2024, included 165 teenage girls aged 13-19 years with anemia (Hb ≤12), excluding known cases of hemolytic anemia or autoimmune disorders, recent blood loss, significant organ dysfunction, psychiatric illness, and ongoing anemia treatment.